IE861739L - Hmg-coa reductase inhibitors - Google Patents

Hmg-coa reductase inhibitors

Info

Publication number
IE861739L
IE861739L IE173986A IE173986A IE861739L IE 861739 L IE861739 L IE 861739L IE 173986 A IE173986 A IE 173986A IE 173986 A IE173986 A IE 173986A IE 861739 L IE861739 L IE 861739L
Authority
IE
Ireland
Prior art keywords
hmg
coa reductase
reductase inhibitors
inhibitors
coa
Prior art date
Application number
IE173986A
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Priority to IE173986A priority Critical patent/IE861739L/en
Publication of IE861739L publication Critical patent/IE861739L/en

Links

IE173986A 1986-06-27 1986-06-27 Hmg-coa reductase inhibitors IE861739L (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IE173986A IE861739L (en) 1986-06-27 1986-06-27 Hmg-coa reductase inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IE173986A IE861739L (en) 1986-06-27 1986-06-27 Hmg-coa reductase inhibitors

Publications (1)

Publication Number Publication Date
IE861739L true IE861739L (en) 1987-01-05

Family

ID=11030608

Family Applications (1)

Application Number Title Priority Date Filing Date
IE173986A IE861739L (en) 1986-06-27 1986-06-27 Hmg-coa reductase inhibitors

Country Status (1)

Country Link
IE (1) IE861739L (en)

Similar Documents

Publication Publication Date Title
EP0211416A3 (en) Novel hmg-coa reductase inhibitors
EP0251625A3 (en) Novel hmg-coa reductase inhibitors
JPS6426535A (en) Novel hmg-coa reductase inhibitor
PH25350A (en) PHOSPHOROUS-CONTAINING HMG-CoA REDUCTASE INHIBITORS
EP0403487A4 (en) Novel hmg-coa reductase inhibitors
PH27278A (en) Spiro-isoquinoline-pyrrolidine tetrones useful as aldose reductase inhibitors
EP0462661A3 (en) Novel 17beta-hydroxybenzoyl-4-aza-5alpha-androst-1-en-3-ones as testosterone reductase inhibitors
GB2205838B (en) Phosphorus-containing hmg-coa reductase inhibitors
AU5758490A (en) Novel acetylcholinesterase inhibitors
ZA886468B (en) Novel hmg-coa reductase inhibitors
EP0323866A3 (en) Novel hmg-coa reductase inhibitors
DE3573780D1 (en) A process for the preparation of hmg-coa reductase inhibitors and intermediate compounds employed therein
JPS6463595A (en) Ribonucleotide reductase inhibitor
EP0415488A3 (en) 7-substituted hmg-coa reductase inhibitors
ZW9087A1 (en) Dopamine-b-hydroxylase inhibitors
EP0306263A3 (en) Novel hmg-coa reductase inhibitors
ZA874487B (en) Novel hmg-coa reductase inhibitors
EP0320052A3 (en) Intermediates and processes for 6-carboxy hmg-coa reductase inhibitors
EP0468974A4 (en) Novel hmg-coa reductase inhibitors
IE861739L (en) Hmg-coa reductase inhibitors
GB2188047B (en) Aldose reductase inhibitor
GB9303051D0 (en) 17b-nmonosubstituted carbamoyl-11-oxo-4-aza-5-a-androst-en-3-one testosterone-5-alpha reductase inhibitors
IE871654L (en) Novel hmg-coa reductase inhibitors
IE851368L (en) Preparing hmg-coa reductase inhibitors
IE882652L (en) NOVEL HMG-CoA REDUCTASE INHIBITORS